vs
KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）与Rhinebeck Bancorp, Inc.（RBKB）财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是Rhinebeck Bancorp, Inc.的1.7倍（$22.6M vs $13.5M），Rhinebeck Bancorp, Inc.净利率更高（17.3% vs -145.3%，领先162.6%），Rhinebeck Bancorp, Inc.自由现金流更多（$10.9M vs $-25.6M）
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
KMTS vs RBKB — 直观对比
营收规模更大
KMTS
是对方的1.7倍
$13.5M
净利率更高
RBKB
高出162.6%
-145.3%
自由现金流更多
RBKB
多$36.5M
$-25.6M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $22.6M | $13.5M |
| 净利润 | $-32.8M | $2.3M |
| 毛利率 | 50.6% | — |
| 营业利润率 | -140.7% | 21.7% |
| 净利率 | -145.3% | 17.3% |
| 营收同比 | — | 1701.1% |
| 净利润同比 | — | 188.0% |
| 每股收益（稀释后） | $-0.64 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTSRBKB
| Q4 25 | $22.6M | $13.5M | ||
| Q3 25 | $19.4M | $14.0M | ||
| Q2 25 | — | $13.1M | ||
| Q1 25 | — | $12.8M | ||
| Q4 24 | — | $750.0K | ||
| Q3 24 | — | $773.0K | ||
| Q2 24 | — | $10.7M | ||
| Q1 24 | — | $10.4M |
净利润KMTSRBKB
| Q4 25 | $-32.8M | $2.3M | ||
| Q3 25 | $-25.8M | $2.7M | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $-8.1M | ||
| Q2 24 | — | $975.0K | ||
| Q1 24 | — | $1.1M |
毛利率KMTSRBKB
| Q4 25 | 50.6% | — | ||
| Q3 25 | 45.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率KMTSRBKB
| Q4 25 | -140.7% | 21.7% | ||
| Q3 25 | -149.1% | 23.9% | ||
| Q2 25 | — | 26.6% | ||
| Q1 25 | — | 22.9% | ||
| Q4 24 | — | -444.9% | ||
| Q3 24 | — | -1332.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 13.9% |
净利率KMTSRBKB
| Q4 25 | -145.3% | 17.3% | ||
| Q3 25 | -133.3% | 19.3% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | -353.9% | ||
| Q3 24 | — | -1042.9% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | 10.8% |
每股收益（稀释后）KMTSRBKB
| Q4 25 | $-0.64 | $0.21 | ||
| Q3 25 | $-0.50 | $0.25 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | — | $-0.75 | ||
| Q2 24 | — | $0.09 | ||
| Q1 24 | — | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $136.9M |
| 总资产 | $246.7M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KMTSRBKB
| Q4 25 | $175.4M | — | ||
| Q3 25 | $201.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KMTSRBKB
| Q4 25 | $164.1M | $136.9M | ||
| Q3 25 | $184.2M | $133.0M | ||
| Q2 25 | — | $129.0M | ||
| Q1 25 | — | $126.0M | ||
| Q4 24 | — | $121.8M | ||
| Q3 24 | — | $122.7M | ||
| Q2 24 | — | $116.2M | ||
| Q1 24 | — | $114.3M |
总资产KMTSRBKB
| Q4 25 | $246.7M | $1.3B | ||
| Q3 25 | $266.3M | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | $10.9M |
| 自由现金流率自由现金流/营收 | -113.5% | 80.6% |
| 资本支出强度资本支出/营收 | 32.2% | 6.3% |
| 现金转化率经营现金流/净利润 | — | 5.03× |
| 过去12个月自由现金流最近4个季度 | — | $19.4M |
8季度趋势，按日历期对齐
经营现金流KMTSRBKB
| Q4 25 | $-18.3M | $11.7M | ||
| Q3 25 | $-26.3M | $2.2M | ||
| Q2 25 | — | $2.4M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-3.6M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $-3.5M |
自由现金流KMTSRBKB
| Q4 25 | $-25.6M | $10.9M | ||
| Q3 25 | $-34.4M | $2.0M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | — | $7.7M | ||
| Q3 24 | — | $-3.6M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $-3.7M |
自由现金流率KMTSRBKB
| Q4 25 | -113.5% | 80.6% | ||
| Q3 25 | -177.8% | 14.5% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 1023.9% | ||
| Q3 24 | — | -469.0% | ||
| Q2 24 | — | 111.1% | ||
| Q1 24 | — | -36.0% |
资本支出强度KMTSRBKB
| Q4 25 | 32.2% | 6.3% | ||
| Q3 25 | 42.2% | 1.4% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 105.5% | ||
| Q3 24 | — | 6.3% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.3% |
现金转化率KMTSRBKB
| Q4 25 | — | 5.03× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.27× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
